|
| |
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Journal of Experimental Biology, Vol 196, Issue 1 375-388, Copyright © 1994 by Company of Biologists
JOURNAL ARTICLES |
JP Reeves, M Condrescu, G Chernaya and JP Gardner
Department of Physiology, University of Medicine and Dentistry, New Jersey Medical School, Newark 07103.
The cardiac Na+/Ca2+ antiporter moves 3 Na+ across the plasma membrane in exchange for a single Ca2+ moving in the opposite direction. It is the principal Ca2+ efflux mechanism in myocardial cells; however, it also contributes to Ca2+ influx under certain conditions. It is particularly abundant in the heart, but is also expressed in other tissues such as smooth and skeletal muscle, the kidney and the brain. The cardiac antiporter itself is a protein of 938 amino acids, with a cleaved NH2-terminal signal sequence, 11 putative transmembrane segments and a large hydrophilic domain of 520 amino acids between the fifth and sixth transmembrane segments. Alternative mRNA splicing mechanisms generate tissue-specific isoforms in a limited region within the hydrophilic domain. Most of the hydrophilic domain can be deleted without altering the kinetics of the transport reaction; the regulatory properties of the antiporter are markedly affected by this deletion however. Two different modes of regulation of antiport activity have been characterized and appear to involve two different inactive states of the carrier. The first is promoted by the presence of cytosolic Na+ in the absence of ATP and the second is promoted by the absence of cytosolic Ca2+. ATP-dependent regulation of antiport activity may involve interactions with the cellular cytoskeleton, since the effects of ATP depletion can be mimicked by cytochalasin D. Ca(2+)-dependent regulation of antiport activity appears to involve the interaction of cytosolic Ca2+ with two acidic amino acid sequences within a limited region of the hydrophilic domain.
This article has been cited by other articles:
|
|
 |
|
  D. O. LEVITSKY Three Types of Muscles Express Three Sodium-Calcium Exchanger Isoforms Ann. N.Y. Acad. Sci., March 1, 2007; 1099(1): 221 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Dipolo and L. Beauge Sodium/Calcium Exchanger: Influence of Metabolic Regulation on Ion Carrier Interactions Physiol Rev, January 1, 2006; 86(1): 155 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Wu and C. H. Fry Na+/Ca2+ exchange and its role in intracellular Ca2+ regulation in guinea pig detrusor smooth muscle Am J Physiol Cell Physiol, May 1, 2001; 280(5): C1090 - C1096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Fraysse, T. Rouaud, M. Millour, J. Fontaine-Perus, M.-F. Gardahaut, and D. O. Levitsky Expression of the Na+/Ca2+ exchanger in skeletal muscle Am J Physiol Cell Physiol, January 1, 2001; 280(1): C146 - C154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Walker and F. G. Spinale THE STRUCTURE AND FUNCTION OF THE CARDIAC MYOCYTE: A REVIEW OF FUNDAMENTAL CONCEPTS J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 375 - 382. [Full Text] [PDF]
|
|
|
|
|
|
M. P. Blaustein and W. J. Lederer Sodium/Calcium Exchange: Its Physiological Implications Physiol Rev, July 1, 1999; 79(3): 763 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Slodzinski and M. P. Blaustein Na+/Ca2+ exchange in neonatal rat heart cells: antisense inhibition and protein half-life Am J Physiol Cell Physiol, August 1, 1998; 275(2): C459 - C467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chen, Z. Zhang, M.-A. Tawiah-Boateng, and P. M. D. Hardwicke A Ca2+-dependent Tryptic Cleavage Site and a Protein Kinase A Phosphorylation Site Are Present in the Ca2+ Regulatory Domain of Scallop Muscle Na+-Ca2+ Exchanger J. Biol. Chem., July 21, 2000; 275(30): 22961 - 22968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-H. Woo and M. Morad Bimodal regulation of Na+-Ca2+ exchanger by beta -adrenergic signaling pathway in shark ventricular myocytes PNAS, February 13, 2001; 98(4): 2023 - 2028. [Abstract] [Full Text] [PDF]
|
|
